OncoQuest Pharmaceuticals Inc (078590) — Cash Flow Reinvestment Rate
OncoQuest Pharmaceuticals Inc (078590) has a Cash Flow Reinvestment Rate of 1.92x as of December 2025, reinvesting ₩1.01 Billion (capex ₩0.00 plus investments ₩1.01 Billion) from operating cash flow of ₩526.70 Million. See 078590 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
OncoQuest Pharmaceuticals Inc Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for OncoQuest Pharmaceuticals Inc across 9 annual periods. For the full cash flow conversion analysis, see OncoQuest Pharmaceuticals Inc cash flow conversion.
Annual Cash Flow Reinvestment Rate for OncoQuest Pharmaceuticals Inc (2014–2025)
Year-by-year capital reinvestment analysis for OncoQuest Pharmaceuticals Inc. See how financially flexible is OncoQuest Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 14.78x | ₩7.17 Billion | ₩485.35 Million | ₩1.18 Billion | ▲ +429.7% |
| 2024 | 2.79x | ₩11.05 Billion | ₩3.96 Billion | ₩2.51 Billion | ▲ +541.0% |
| 2023 | 0.44x | ₩4.87 Billion | ₩11.19 Billion | ₩1.90 Billion | ▼ -89.2% |
| 2020 | 4.04x | ₩30.48 Billion | ₩7.55 Billion | ₩3.48 Billion | ▼ -15.0% |
| 2018 | 4.75x | ₩6.84 Billion | ₩1.44 Billion | ₩1.33 Billion | ▲ +254.0% |
| 2017 | 1.34x | ₩6.43 Billion | ₩4.79 Billion | ₩1.28 Billion | ▲ +187.2% |
| 2016 | 0.47x | ₩1.65 Billion | ₩3.54 Billion | ₩1.61 Billion | ▼ -55.8% |
| 2015 | 1.06x | ₩2.95 Billion | ₩2.79 Billion | ₩2.91 Billion | ▼ -13.8% |
| 2014 | 1.23x | ₩1.24 Billion | ₩1.02 Billion | ₩1.18 Billion | — |